'Untenable' tweaks enlarging scope of Indian price control
This article was originally published in Scrip
Executive Summary
Tweaks in India's new drug prices control order (DPCO) are threatening to squeeze more from the pharmaceutical industry pulling price caps down further down on the domestic market.